As of the 1st of July, the following changes will apply:
|Vaccine||Brand Name||Scheduled Event||Route||New/Replaces|
|1.||Rotavirus vaccine (RV)||Rotarix||6 weeks, 3 months||Oral||Replaces 3 dose regimen of Rotateq at 6 weeks, 3 months and 5 months.|
|2.||10-valent pneumococcal vaccine (PCV10)||Synflorix||6 weeks, 3, 5, & 15 months||IM||Replaces 13-valent pneumococcal conjugate vaccine (PCV13, Prevenar 13) event at 6 weeks, 3, 5, and 15 months^|
|3.||Varicella vaccine (VV)||Varilrix||15 months*||SC||New on schedule|
|4.||MMR (measles, mumps and rubella)||Priorix||15 months, 4 years||SC||Replaces MMR-II|
|5.||Haemophilus influenzae type b (Hib)||Hiberix||15 months||IM||Replaces Act-Hib|
Funding criteria for high-risk patients remain unchanged.
^Prevenar 13 will remain available for high-risk patients only.
*Varicella vaccine is funded for children born on or after 1 April 2016, at their 15 month immunisation event. It is also funded for children who turn age 11 years on or after 1 July 2017 if they have not previously been infected with chickenpox or vaccinated against it.
With the addition of the varicella vaccine, there are now 4 vaccinations at 15 months. We highly recommend all 4 are administered in one visit, as extra visits mean more stressful and painful vaccination experiences for your child. This practice is completely safe and means you will not have to schedule additional visits to make sure your child is protected.
From the 1st of April 2018 the Zostavax vaccine will be free for those 65+.
To see the new schedule and other information, click here.